National and Kapodistrian University of Athens
Συσχέτιση αδενοκαρκινώματος οισοφάγου με την Β-κατενίνη
Abstract
dc:descriptionIntroduction: Esophageal cancer is considered the ninth most common type of cancer and the sixth leading cause of cancer-related death worldwide. Esophageal adenocarcinoma is associated with aberrant expression of β-Catenin and the transmembrane protein E-Cadherin. The role of β-Catenin is important in intracellular signal transduction through the Wnt pathway, which plays a critical role in the development of esophageal cancer. β-Catenin plays a central role as an adaptor protein, linking E-Cadherin to the actin cytoskeleton, which is essential for maintaining cell adhesion. Aim: To clarify the role of β-Catenin, E-Cadherin and the Wnt pathway, as well as the expression levels of β-Catenin and E-Cadherin as potential biomarkers. Material and method: This study used a pooled sample of eligible anonymized esophagectomy specimens from 71 patients (n=71) with esophageal adenocarcinoma, with or without prior treatments, during the study period (2023-2025), in order to investigate the association between esophageal adenocarcinoma and β-Catenin. The specimens used for this study are archival material from the 1st Laboratory of Pathological Anatomy, Athens Medical School, National and Kapodistrian University of Athens. Results: A total of 71 histopathologically confirmed cases of esophageal adenocarcinoma were examined. After immunohistochemical investigation of the expression of E-Cadherin and B-Catenin, a moderate positive correlation was found between cytoplasmic B-Catenin and TRG (Tumor Regression Grade). A strong positive correlation was also found between cytoplasmic and nuclear B-Catenin expression. Increased cytoplasmic expression was associated with increased nuclear B-Catenin expression, indicating activation of the Wnt pathway. In addition, a positive correlation was found between E-Cadherin and TRG expression. The higher the expression of E-Cadherin, the better the response to treatment.Conclusions: Simultaneous targeting of B-Catenin and E-Cadherin could provide therapeutic benefits in esophageal adenocarcinoma and could potentially be used as prognostic biomarkers.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ntourakis, Alexandros
- Ντουράκης, Αλέξανδρος
Subjects
dc:subject × 15- Αδενοκαρκίνωμα Barrett
- Πλακώδες καρκίνωμα επιθηλίου
- Οισοφαγικός καρκίνος
- Πυρηνική έκφραση
- β-catenin
- Ε-Cadherin
- Wnt signaling pathway
- Trg
- mRNA
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Παθολογοανατομία και Ιατροδικαστική
- Other Medical Sciences
- Medical and Health Sciences
- Pathology and Forensic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60746